Pre-order Enquiry
Request Free Sample
Global Peripheral Arterial Disease (PAD) Drugs Market Size, Status and Forecast 2021-2027
SKU ID : QYR-17246813 | Publishing Date : 22-Jan-2021 | No. of pages : 93
Detailed TOC of Global Peripheral Arterial Disease (PAD) Drugs Market Size, Status and Forecast 2021-2027
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peripheral Arterial Disease (PAD) Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Clopidogrel (Plavix)
1.2.3 Prasugrel (Effient)
1.2.4 Ticagrelor (Brilinta)
1.2.5 Vorapaxar (Zontivity)
1.2.6 Others
1.3 Market by Application
1.3.1 Global Peripheral Arterial Disease (PAD) Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Peripheral Arterial Disease (PAD) Drugs Market Perspective (2016-2027)
2.2 Peripheral Arterial Disease (PAD) Drugs Growth Trends by Regions
2.2.1 Peripheral Arterial Disease (PAD) Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Peripheral Arterial Disease (PAD) Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Peripheral Arterial Disease (PAD) Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Peripheral Arterial Disease (PAD) Drugs Industry Dynamic
2.3.1 Peripheral Arterial Disease (PAD) Drugs Market Trends
2.3.2 Peripheral Arterial Disease (PAD) Drugs Market Drivers
2.3.3 Peripheral Arterial Disease (PAD) Drugs Market Challenges
2.3.4 Peripheral Arterial Disease (PAD) Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peripheral Arterial Disease (PAD) Drugs Players by Revenue
3.1.1 Global Top Peripheral Arterial Disease (PAD) Drugs Players by Revenue (2016-2021)
3.1.2 Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Peripheral Arterial Disease (PAD) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Peripheral Arterial Disease (PAD) Drugs Revenue
3.4 Global Peripheral Arterial Disease (PAD) Drugs Market Concentration Ratio
3.4.1 Global Peripheral Arterial Disease (PAD) Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peripheral Arterial Disease (PAD) Drugs Revenue in 2020
3.5 Peripheral Arterial Disease (PAD) Drugs Key Players Head office and Area Served
3.6 Key Players Peripheral Arterial Disease (PAD) Drugs Product Solution and Service
3.7 Date of Enter into Peripheral Arterial Disease (PAD) Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Peripheral Arterial Disease (PAD) Drugs Breakdown Data by Type
4.1 Global Peripheral Arterial Disease (PAD) Drugs Historic Market Size by Type (2016-2021)
4.2 Global Peripheral Arterial Disease (PAD) Drugs Forecasted Market Size by Type (2022-2027)
5 Peripheral Arterial Disease (PAD) Drugs Breakdown Data by Application
5.1 Global Peripheral Arterial Disease (PAD) Drugs Historic Market Size by Application (2016-2021)
5.2 Global Peripheral Arterial Disease (PAD) Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Peripheral Arterial Disease (PAD) Drugs Market Size (2016-2027)
6.2 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Type
6.2.1 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2021)
6.2.2 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2022-2027)
6.2.3 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2027)
6.3 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Application
6.3.1 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2021)
6.3.2 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2022-2027)
6.3.3 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2027)
6.4 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Country
6.4.1 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2016-2021)
6.4.2 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Peripheral Arterial Disease (PAD) Drugs Market Size (2016-2027)
7.2 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Type
7.2.1 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2021)
7.2.2 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2022-2027)
7.2.3 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2027)
7.3 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Application
7.3.1 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2021)
7.3.2 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2022-2027)
7.3.3 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2027)
7.4 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Country
7.4.1 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2016-2021)
7.4.2 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size (2016-2027)
8.2 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Type
8.2.1 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Application
8.3.1 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Region
8.4.1 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size (2016-2027)
9.2 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Type
9.2.1 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2027)
9.3 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Application
9.3.1 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2027)
9.4 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Country
9.4.1 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size (2016-2027)
10.2 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Type
10.2.1 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Application
10.3.1 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Country
10.4.1 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AstraZeneca Plc. (UK)
11.1.1 AstraZeneca Plc. (UK) Company Details
11.1.2 AstraZeneca Plc. (UK) Business Overview
11.1.3 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Drugs Introduction
11.1.4 AstraZeneca Plc. (UK) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021)
11.1.5 AstraZeneca Plc. (UK) Recent Development
11.2 Bayer HealthCare Pharmaceuticals (Germany)
11.2.1 Bayer HealthCare Pharmaceuticals (Germany) Company Details
11.2.2 Bayer HealthCare Pharmaceuticals (Germany) Business Overview
11.2.3 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Drugs Introduction
11.2.4 Bayer HealthCare Pharmaceuticals (Germany) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021)
11.2.5 Bayer HealthCare Pharmaceuticals (Germany) Recent Development
11.3 Bristol-Myers Squibb Company (US)
11.3.1 Bristol-Myers Squibb Company (US) Company Details
11.3.2 Bristol-Myers Squibb Company (US) Business Overview
11.3.3 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Drugs Introduction
11.3.4 Bristol-Myers Squibb Company (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021)
11.3.5 Bristol-Myers Squibb Company (US) Recent Development
11.4 Merck & Co., Inc. (US)
11.4.1 Merck & Co., Inc. (US) Company Details
11.4.2 Merck & Co., Inc. (US) Business Overview
11.4.3 Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Drugs Introduction
11.4.4 Merck & Co., Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021)
11.4.5 Merck & Co., Inc. (US) Recent Development
11.5 Proteon Therapeutics, Inc. (US)
11.5.1 Proteon Therapeutics, Inc. (US) Company Details
11.5.2 Proteon Therapeutics, Inc. (US) Business Overview
11.5.3 Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Drugs Introduction
11.5.4 Proteon Therapeutics, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021)
11.5.5 Proteon Therapeutics, Inc. (US) Recent Development
11.6 Sanofi S.A. (France)
11.6.1 Sanofi S.A. (France) Company Details
11.6.2 Sanofi S.A. (France) Business Overview
11.6.3 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Drugs Introduction
11.6.4 Sanofi S.A. (France) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021)
11.6.5 Sanofi S.A. (France) Recent Development
11.7 Symic Bio, Inc. (US)
11.7.1 Symic Bio, Inc. (US) Company Details
11.7.2 Symic Bio, Inc. (US) Business Overview
11.7.3 Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Drugs Introduction
11.7.4 Symic Bio, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021)
11.7.5 Symic Bio, Inc. (US) Recent Development
11.8 TheraVasc Inc. (US)
11.8.1 TheraVasc Inc. (US) Company Details
11.8.2 TheraVasc Inc. (US) Business Overview
11.8.3 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Drugs Introduction
11.8.4 TheraVasc Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021)
11.8.5 TheraVasc Inc. (US) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Peripheral Arterial Disease (PAD) Drugs Market Size, Status and Forecast 2021-2027
List of TablesTable 1. Global Peripheral Arterial Disease (PAD) Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Clopidogrel (Plavix)
Table 3. Key Players of Prasugrel (Effient)
Table 4. Key Players of Ticagrelor (Brilinta)
Table 5. Key Players of Vorapaxar (Zontivity)
Table 6. Key Players of Others
Table 7. Global Peripheral Arterial Disease (PAD) Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Peripheral Arterial Disease (PAD) Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Peripheral Arterial Disease (PAD) Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Peripheral Arterial Disease (PAD) Drugs Market Share by Regions (2016-2021)
Table 11. Global Peripheral Arterial Disease (PAD) Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Peripheral Arterial Disease (PAD) Drugs Market Share by Regions (2022-2027)
Table 13. Peripheral Arterial Disease (PAD) Drugs Market Trends
Table 14. Peripheral Arterial Disease (PAD) Drugs Market Drivers
Table 15. Peripheral Arterial Disease (PAD) Drugs Market Challenges
Table 16. Peripheral Arterial Disease (PAD) Drugs Market Restraints
Table 17. Global Peripheral Arterial Disease (PAD) Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Peripheral Arterial Disease (PAD) Drugs Market Share by Players (2016-2021)
Table 19. Global Top Peripheral Arterial Disease (PAD) Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peripheral Arterial Disease (PAD) Drugs as of 2020)
Table 20. Ranking of Global Top Peripheral Arterial Disease (PAD) Drugs Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Peripheral Arterial Disease (PAD) Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Peripheral Arterial Disease (PAD) Drugs Product Solution and Service
Table 24. Date of Enter into Peripheral Arterial Disease (PAD) Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Type (2016-2021)
Table 28. Global Peripheral Arterial Disease (PAD) Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Peripheral Arterial Disease (PAD) Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Application (2016-2021)
Table 32. Global Peripheral Arterial Disease (PAD) Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 64. AstraZeneca Plc. (UK) Company Details
Table 65. AstraZeneca Plc. (UK) Business Overview
Table 66. AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Drugs Product
Table 67. AstraZeneca Plc. (UK) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) & (US$ Million)
Table 68. AstraZeneca Plc. (UK) Recent Development
Table 69. Bayer HealthCare Pharmaceuticals (Germany) Company Details
Table 70. Bayer HealthCare Pharmaceuticals (Germany) Business Overview
Table 71. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Drugs Product
Table 72. Bayer HealthCare Pharmaceuticals (Germany) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) & (US$ Million)
Table 73. Bayer HealthCare Pharmaceuticals (Germany) Recent Development
Table 74. Bristol-Myers Squibb Company (US) Company Details
Table 75. Bristol-Myers Squibb Company (US) Business Overview
Table 76. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Drugs Product
Table 77. Bristol-Myers Squibb Company (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) & (US$ Million)
Table 78. Bristol-Myers Squibb Company (US) Recent Development
Table 79. Merck & Co., Inc. (US) Company Details
Table 80. Merck & Co., Inc. (US) Business Overview
Table 81. Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Drugs Product
Table 82. Merck & Co., Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) & (US$ Million)
Table 83. Merck & Co., Inc. (US) Recent Development
Table 84. Proteon Therapeutics, Inc. (US) Company Details
Table 85. Proteon Therapeutics, Inc. (US) Business Overview
Table 86. Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Drugs Product
Table 87. Proteon Therapeutics, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) & (US$ Million)
Table 88. Proteon Therapeutics, Inc. (US) Recent Development
Table 89. Sanofi S.A. (France) Company Details
Table 90. Sanofi S.A. (France) Business Overview
Table 91. Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Drugs Product
Table 92. Sanofi S.A. (France) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) & (US$ Million)
Table 93. Sanofi S.A. (France) Recent Development
Table 94. Symic Bio, Inc. (US) Company Details
Table 95. Symic Bio, Inc. (US) Business Overview
Table 96. Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Drugs Product
Table 97. Symic Bio, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) & (US$ Million)
Table 98. Symic Bio, Inc. (US) Recent Development
Table 99. TheraVasc Inc. (US) Company Details
Table 100. TheraVasc Inc. (US) Business Overview
Table 101. TheraVasc Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) & (US$ Million)
Table 102. TheraVasc Inc. (US) Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peripheral Arterial Disease (PAD) Drugs Market Share by Type: 2020 VS 2027
Figure 2. Clopidogrel (Plavix) Features
Figure 3. Prasugrel (Effient) Features
Figure 4. Ticagrelor (Brilinta) Features
Figure 5. Vorapaxar (Zontivity) Features
Figure 6. Others Features
Figure 7. Global Peripheral Arterial Disease (PAD) Drugs Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Peripheral Arterial Disease (PAD) Drugs Report Years Considered
Figure 12. Global Peripheral Arterial Disease (PAD) Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Peripheral Arterial Disease (PAD) Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Peripheral Arterial Disease (PAD) Drugs Market Share by Regions: 2020 VS 2027
Figure 15. Global Peripheral Arterial Disease (PAD) Drugs Market Share by Regions (2022-2027)
Figure 16. Global Peripheral Arterial Disease (PAD) Drugs Market Share by Players in 2020
Figure 17. Global Top Peripheral Arterial Disease (PAD) Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peripheral Arterial Disease (PAD) Drugs as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Peripheral Arterial Disease (PAD) Drugs Revenue in 2020
Figure 19. Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Type (2016-2021)
Figure 20. Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Type (2022-2027)
Figure 21. North America Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Peripheral Arterial Disease (PAD) Drugs Market Share by Type (2016-2027)
Figure 23. North America Peripheral Arterial Disease (PAD) Drugs Market Share by Application (2016-2027)
Figure 24. North America Peripheral Arterial Disease (PAD) Drugs Market Share by Country (2016-2027)
Figure 25. United States Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Peripheral Arterial Disease (PAD) Drugs Market Share by Type (2016-2027)
Figure 29. Europe Peripheral Arterial Disease (PAD) Drugs Market Share by Application (2016-2027)
Figure 30. Europe Peripheral Arterial Disease (PAD) Drugs Market Share by Country (2016-2027)
Figure 31. Germany Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Share by Region (2016-2027)
Figure 41. China Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Peripheral Arterial Disease (PAD) Drugs Market Share by Type (2016-2027)
Figure 49. Latin America Peripheral Arterial Disease (PAD) Drugs Market Share by Application (2016-2027)
Figure 50. Latin America Peripheral Arterial Disease (PAD) Drugs Market Share by Country (2016-2027)
Figure 51. Mexico Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Share by Country (2016-2027)
Figure 57. Turkey Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. AstraZeneca Plc. (UK) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021)
Figure 61. Bayer HealthCare Pharmaceuticals (Germany) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021)
Figure 62. Bristol-Myers Squibb Company (US) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021)
Figure 63. Merck & Co., Inc. (US) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021)
Figure 64. Proteon Therapeutics, Inc. (US) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021)
Figure 65. Sanofi S.A. (France) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021)
Figure 66. Symic Bio, Inc. (US) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021)
Figure 67. TheraVasc Inc. (US) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Keyplayers in Global Peripheral Arterial Disease (PAD) Drugs Market Size, Status and Forecast 2021-2027
AstraZeneca Plc. (UK)Bayer HealthCare Pharmaceuticals (Germany)
Bristol-Myers Squibb Company (US)
Merck & Co., Inc. (US)
Proteon Therapeutics, Inc. (US)
Sanofi S.A. (France)
Symic Bio, Inc. (US)
TheraVasc Inc. (US)
Request Sample
Request Discount
